|
|
Led by Dr.
R. Patrick Dorion, the Geisinger Medical Laboratories Head and
Neck Pathology Subspecialists specialize in diagnosing diseases of
the:
- head and neck
- salivary glands
- sinuses
- tonsils
- nasal cavity
- oral cavity
- pharynx
- larynx
- upper respiratory tract
The group has also published articles on their specialty in peer-reviwed journals and presented at national and international conferences:
- Zhang PL, Pellitteri PK, Law A, Gilroy PA, Wood GC, Kennedy TL, Blasick TM, Lun M, Schuerch C, Brown RE. Overexpression of Phosphorylated Nuclear Factor-kappaB in Tonsillar Squamous Cell Carcinoma and High Grade Dysplasia is Associated with Poor Prognosis. Abstract 94th Annual USACP Meeting, San Antonio, TX, February 26, 2005.
- Brown RE, Zhang PL, Lun M, Zhu S, Pellitteir PK, Law A, Wood GC, Kenedy Tl. Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma. Ann Clin Lab Sci 36: 273-282, 2006.
- Akervall J, Kurnit DM, Adams M, Zhu S, Fisher SG, Bradford CR, Carey TE. Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck. Acta Oto-Laryngologica 124(7):857-857, 2004.
- Bradford CR. Zhu S. Ogawa H. Ogawa T. Ubell M. Narayan A. Johnson G. Wolf GT. Fisher SG. Carey TE. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head & Neck. 25(8):654-61, 2003
|
|
